20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells

20-Hydroxyecdysone (20E) is an arthropod hormone which is synthesized by some plants as part of their defense mechanism. In humans, 20E has no hormonal activity but possesses a number of beneficial pharmacological properties including anabolic, adaptogenic, hypoglycemic, and antioxidant properties, as well as cardio-, hepato-, and neuroprotective features. Recent studies have shown that 20E may also possess antineoplastic activity. In the present study, we reveal the anticancer properties of 20E in Non-Small Cell Lung Cancer (NSCLC) cell lines. 20E displayed significant antioxidant capacities and induced the expression of antioxidative stress response genes. The RNA-seq analysis of 20E-treated lung cancer cells revealed the attenuation of genes involved in different metabolic processes. Indeed, 20E suppressed several enzymes of glycolysis and one-carbon metabolism, as well as their key transcriptional regulators—c-Myc and ATF4, respectively. Accordingly, using the SeaHorse energy profiling approach, we observed the inhibition of glycolysis and respiration mediated by 20E treatment. Furthermore, 20E sensibilized lung cancer cells to metabolic inhibitors and markedly suppressed the expression of Cancer Stem Cells (CSCs) markers. Thus, in addition to the known beneficial pharmacological activities of 20E, our data uncovered novel antineoplastic properties of 20E in NSCLC cells.

[1]  H. Xiong,et al.  Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer , 2023, Frontiers in Oncology.

[2]  Fu-ming Zi,et al.  A pan-cancer analysis of the role of hexokinase II (HK2) in human tumors , 2022, Scientific Reports.

[3]  Jaemoo Chun,et al.  A Comprehensive Analysis and Anti-Cancer Activities of Quercetin in ROS-Mediated Cancer and Cancer Stem Cells , 2022, International journal of molecular sciences.

[4]  Cheorl-Ho Kim,et al.  Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells , 2022, International journal of molecular sciences.

[5]  Liangdong Li,et al.  An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy , 2022, Frontiers in Genetics.

[6]  H. Shan,et al.  Gankyrin modulated non-small cell lung cancer progression via glycolysis metabolism in a YAP1-dependent manner , 2022, Cell death discovery.

[7]  Hongyu Liu,et al.  Tumor metabolic reprogramming in lung cancer progression , 2022, Oncology letters.

[8]  Yue Zheng,et al.  Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies , 2022, Frontiers in Oncology.

[9]  Hongxin Ren,et al.  Kruppel like factor 16 promotes lung adenocarcinoma progression by upregulating lamin B2 , 2022, Bioengineered.

[10]  M. Videira,et al.  Akt/mTOR Activation in Lung Cancer Tumorigenic Regulators and Their Potential Value as Biomarkers , 2022, Onco.

[11]  F. Kobeissy,et al.  Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  Ling Deng,et al.  Phosphoserine phosphatase as a prognostic biomarker in patients with gastric cancer and its potential association with immune cells , 2022, BMC Gastroenterology.

[13]  Mahdi Ramezani,et al.  Effects of the combination of high-intensity interval training and Ecdysterone on learning and memory abilities, antioxidant enzyme activities, and neuronal population in an Amyloid-beta-induced rat model of Alzheimer's disease , 2021, Physiology & Behavior.

[14]  Yida Lu,et al.  High ATF4 Expression Is Associated With Poor Prognosis, Amino Acid Metabolism, and Autophagy in Gastric Cancer , 2021, Frontiers in Oncology.

[15]  G. Jaramillo-Rangel,et al.  Nestin-Expressing Cells in the Lung: The Bad and the Good Parts , 2021, Cells.

[16]  A. Quarta,et al.  Beneficial Oxidative Stress-Related trans-Resveratrol Effects in the Treatment and Prevention of Breast Cancer , 2021, Applied Sciences.

[17]  M. Serova,et al.  20-Hydroxyecdysone activates the protective arm of the RAAS via Mas receptor. , 2021, Journal of molecular endocrinology.

[18]  N. Barlev,et al.  p53-Independent Effects of Set7/9 Lysine Methyltransferase on Metabolism of Non-Small Cell Lung Cancer Cells , 2021, Frontiers in Oncology.

[19]  Jing Wang,et al.  Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer , 2021, Cancer & Metabolism.

[20]  H. Ding,et al.  ATF3 promotes the serine synthesis pathway and tumor growth under dietary serine restriction , 2021, Cell reports.

[21]  Lili Huang,et al.  Targeting Reactive Oxygen Species Capacity of Tumor Cells with Repurposed Drug as an Anticancer Therapy , 2021, Oxidative medicine and cellular longevity.

[22]  Z. Fan,et al.  The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer , 2021, Frontiers in Oncology.

[23]  Z. Lorigooini,et al.  Rutin: A Flavonoid as an Effective Sensitizer for Anticancer Therapy; Insights into Multifaceted Mechanisms and Applicability for Combination Therapy , 2021, Evidence-based complementary and alternative medicine : eCAM.

[24]  C. Pilarsky,et al.  Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting , 2021, Journal of Experimental & Clinical Cancer Research.

[25]  K. Takada,et al.  Reactive oxygen species in cancer: Current findings and future directions , 2021, Cancer science.

[26]  T. Friedemann,et al.  Ecdysterone Attenuates the Development of Radiation-Induced Oral Mucositis in Rats at Early Stage , 2021, Radiation Research.

[27]  A. Lánczky,et al.  Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation , 2021, Journal of medical Internet research.

[28]  Baoli Li,et al.  The Role of Notch3 Signaling in Cancer Stemness and Chemoresistance: Molecular Mechanisms and Targeting Strategies , 2021, Frontiers in Molecular Biosciences.

[29]  Qian Yang,et al.  Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer , 2021, Frontiers in Genetics.

[30]  L. Dinan,et al.  20-Hydroxyecdysone, from Plant Extracts to Clinical Use: Therapeutic Potential for the Treatment of Neuromuscular, Cardio-Metabolic and Respiratory Diseases , 2021, Biomedicines.

[31]  N. Lisiak,et al.  Proapoptotic and proautophagic activity of 20-hydroxyecdysone in breast cancer cells in vitro. , 2021, Chemico-biological interactions.

[32]  N. Neamati,et al.  A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight. , 2021, ACS pharmacology & translational science.

[33]  C. Tourette,et al.  Ecdysteroid metabolism in mammals: The fate of ingested 20-hydroxyecdysone in mice and rats , 2021, The Journal of Steroid Biochemistry and Molecular Biology.

[34]  P. Dilda,et al.  Developing new drugs that activate the protective arm of the renin–angiotensin system as a potential treatment for respiratory failure in COVID-19 patients , 2021, Drug Discovery Today.

[35]  N. Barlev,et al.  Linking Metabolic Reprogramming, Plasticity and Tumor Progression , 2021, Cancers.

[36]  O. Sansom,et al.  Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy , 2021, Nature Communications.

[37]  Huijuan Wang,et al.  Serine, glycine and one-carbon metabolism in cancer (Review) , 2020, International journal of oncology.

[38]  O. Fedorova,et al.  SEMG1/2 augment energy metabolism of tumor cells , 2020, Cell Death & Disease.

[39]  G. Spengler,et al.  In vitro adjuvant antitumor activity of various classes of semi-synthetic poststerone derivatives. , 2020, Bioorganic chemistry.

[40]  Yongzhen Peng,et al.  The Potential of Lonidamine in Combination with Chemotherapy and Physical Therapy in Cancer Treatment , 2020, Cancers.

[41]  O. Fedorova,et al.  An Arthropod Hormone, Ecdysterone, Inhibits the Growth of Breast Cancer Cells via Different Mechanisms , 2020, Frontiers in Pharmacology.

[42]  Kwok-Kin Wong,et al.  Shining a light on metabolic vulnerabilities in non-small cell lung cancer. , 2020, Biochimica et biophysica acta. Reviews on cancer.

[43]  Wei Li,et al.  The Role and Specific Mechanism of OCT4 in Cancer Stem Cells: A Review , 2020, International journal of stem cells.

[44]  G. Viola,et al.  Ecdysteroid Derivatives that Reverse P-Glycoprotein-Mediated Drug Resistance , 2020, Journal of natural products.

[45]  T. Yevsa,et al.  Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies , 2020, Frontiers in Immunology.

[46]  Sebastian Sorge,et al.  ATF4-Induced Warburg Metabolism Drives Over-Proliferation in Drosophila. , 2020, Cell reports.

[47]  G. Sethi,et al.  The multifaceted role of reactive oxygen species in tumorigenesis , 2020, Cellular and Molecular Life Sciences.

[48]  B. Perillo,et al.  ROS in cancer therapy: the bright side of the moon , 2020, Experimental & Molecular Medicine.

[49]  J. Serpa,et al.  Metabolic Remodelling: An Accomplice for New Therapeutic Strategies to Fight Lung Cancer , 2019, Antioxidants.

[50]  P. Adriaensens,et al.  The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism , 2019, Front. Oncol..

[51]  James R. Smith,et al.  ROS as a novel indicator to predict anticancer drug efficacy , 2019, BMC Cancer.

[52]  B. Salehi,et al.  Kaempferol: A Key Emphasis to Its Anticancer Potential , 2019, Molecules.

[53]  X. de la Torre,et al.  Ecdysteroids as non-conventional anabolic agent: performance enhancement by ecdysterone supplementation in humans , 2019, Archives of Toxicology.

[54]  Yongzhen Peng,et al.  Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment , 2019, Cancers.

[55]  R. Rosell,et al.  Cancer Stem Cell Biomarkers in EGFR-Mutation-Positive Non-Small-Cell Lung Cancer. , 2019, Clinical lung cancer.

[56]  Weimin Li,et al.  FRK plays an oncogenic role in non‐small cell lung cancer by enhancing the stemness phenotype via induction of metabolic reprogramming , 2019, International journal of cancer.

[57]  R. Carpenter,et al.  HSF1 as a Cancer Biomarker and Therapeutic Target. , 2019, Current cancer drug targets.

[58]  Yong Lin,et al.  Association Between c-Myc and Colorectal Cancer Prognosis: A Meta-Analysis , 2018, Front. Physiol..

[59]  S. Ganapathy-Kanniappan,et al.  Molecular intricacies of aerobic glycolysis in cancer: current insights into the classic metabolic phenotype , 2018, Critical reviews in biochemistry and molecular biology.

[60]  L. Kma,et al.  Dysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells , 2018, Asian Pacific journal of cancer prevention : APJCP.

[61]  J. Blenis,et al.  Beyond the Warburg Effect: How Do Cancer Cells Regulate One-Carbon Metabolism? , 2018, Front. Cell Dev. Biol..

[62]  Yingbo Li,et al.  LDHA upregulation independently predicts poor survival in lung adenocarcinoma, but not in lung squamous cell carcinoma. , 2018, Future oncology.

[63]  E. Prochownik,et al.  The Role for Myc in Coordinating Glycolysis, Oxidative Phosphorylation, Glutaminolysis, and Fatty Acid Metabolism in Normal and Neoplastic Tissues , 2018, Front. Endocrinol..

[64]  D. Prabavathy,et al.  Lung cancer stem cells-origin, characteristics and therapy. , 2018, Stem cell investigation.

[65]  T. S. Ramasamy,et al.  Cancer stem cells as key drivers of tumour progression , 2018, Journal of Biomedical Science.

[66]  Yue Yang,et al.  CD44 promotes cell proliferation in non-small cell lung cancer , 2018, Oncology letters.

[67]  I. Zupkó,et al.  Nitrogen-containing ecdysteroid derivatives vs. multi-drug resistance in cancer: Preparation and antitumor activity of oximes, oxime ethers and a lactam. , 2018, European journal of medicinal chemistry.

[68]  N. Barlev,et al.  Nutlin sensitizes lung carcinoma cells to interferon-alpha treatment in MDM2-dependent but p53-independent manner. , 2018, Biochemical and biophysical research communications.

[69]  David M. Evans,et al.  3D Models of the NCI60 Cell Lines for Screening Oncology Compounds , 2017, SLAS discovery : advancing life sciences R & D.

[70]  N. Barlev,et al.  One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy , 2017, Oncotarget.

[71]  Lei Wang,et al.  Knockdown of SOX12 expression inhibits the proliferation and metastasis of lung cancer cells. , 2017, American journal of translational research.

[72]  Z. Kele,et al.  Ecdysteroid-containing food supplements from Cyanotis arachnoidea on the European market: evidence for spinach product counterfeiting , 2016, Scientific Reports.

[73]  W. Wang,et al.  High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer1 , 2016, Translational oncology.

[74]  Huaming Sheng,et al.  Glycolysis Inhibitors for Anticancer Therapy: A Review of Recent Patents. , 2016, Recent patents on anti-cancer drug discovery.

[75]  Jenny C. Chang.  Cancer stem cells , 2016, Medicine.

[76]  W. Berger,et al.  Ecdysteroids Sensitize MDR and Non-MDR Cancer Cell Lines to Doxorubicin, Paclitaxel, and Vincristine but Tend to Protect Them from Cisplatin , 2015, BioMed research international.

[77]  M. Xie,et al.  Estrogen receptor beta is involved in skeletal muscle hypertrophy induced by the phytoecdysteroid ecdysterone. , 2014, Molecular nutrition & food research.

[78]  E. Calabrese.  Biphasic dose responses in biology, toxicology and medicine: accounting for their generalizability and quantitative features. , 2013, Environmental pollution.

[79]  J. Molnár,et al.  Significant activity of ecdysteroids on the resistance to doxorubicin in mammalian cancer cells expressing the human ABCB1 transporter. , 2012, Journal of medicinal chemistry.

[80]  Xia Bai,et al.  [Research on relationship between tissue quantitative distribution of 3H-Achyranthes bidentata ecdysterone and channel-tropism of herbal drugs in mice]. , 2011, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[81]  L. Opletal,et al.  Ecdysterone and its Activity on some Degenerative Diseases , 2011, Natural product communications.

[82]  A. Lokshin,et al.  Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop. , 2010, Cancer research.

[83]  N. Konovalova,et al.  Ecdysterone Modulates Antitumor Activity of Cytostatics and Biosynthesis of Macromolecules in Tumor-Bearing Mice , 2002, Biology Bulletin of the Russian Academy of Sciences.

[84]  Zhong‐Li Liu,et al.  Antioxidative and free radical scavenging effects of ecdysteroids from Serratula strangulata. , 2002, Canadian journal of physiology and pharmacology.

[85]  E. Niki,et al.  New Functions of 20-Hydroxyecdysone in Lipid Peroxidation , 2001 .

[86]  M. Bounias.  Biphasic regulation in ligand-receptor interactions. , 1990, Journal of enzyme inhibition.

[87]  U. Munderloh,et al.  The effects of 20-hydroxyecdysone and juvenile hormone III on tick cells. , 1983, The Journal of parasitology.